Related Experiment Video
Updated: Oct 27, 2025
Fabrication of Electrochemical-DNA Biosensors for the Reagentless Detection of Nucleic Acids, Proteins and Small Molecules
Published on: June 1, 2011
Electric field-enhanced electrochemical CRISPR biosensor for DNA detection.
Ziyue Li1, Xiong Ding2, Kun Yin2
1Department of Biomedical Engineering, University of Connecticut Health Center, 263 Farmington Ave., Farmington, CT 06030, United States; Department of Biomedical Engineering, University of Connecticut, 260 Glenbrook Road, Storrs, CT 06029, United States.
We developed a novel electric field-enhanced (EFE) electrochemical CRISPR biosensor for sensitive DNA detection. This method simplifies nucleic acid diagnostics and detects human papillomavirus-16 (HPV-16) DNA in clinical samples.
Area of Science:
- Biomedical Engineering
- Molecular Diagnostics
- Biosensor Technology
Background:
- DNA detection is crucial for early cancer screening and infectious disease diagnosis.
- Current methods often require complex procedures or lack sufficient sensitivity.
- A need exists for simple, sensitive, and robust nucleic acid detection platforms.
Purpose of the Study:
- To develop a versatile, electric field-enhanced (EFE) electrochemical CRISPR biosensor for homogeneous DNA detection.
- To improve sensitivity through electric field-induced nucleic acid enrichment.
- To enable sensitive detection of specific DNA targets without complex probe immobilization.
Main Methods:
- Development of an EFE electrochemical CRISPR biosensor utilizing pulsed electric fields for nucleic acid enrichment.
- Exploitation of diffusivity differences between probes and cleaved products for electrochemical detection.
- Direct detection of unamplified human papillomavirus-16 (HPV-16) DNA.
- Coupling the biosensor with recombinase polymerase amplification (RPA) for clinical sample analysis.
Main Results:
- The EFE electrochemical CRISPR biosensor achieved a sensitivity of 1 pM for unamplified HPV-16 DNA.
- The biosensor demonstrated a simple and sensitive electrochemical detection method.
- Successful detection of HPV-16 DNA in clinical samples when combined with RPA.
Conclusions:
- The EFE electrochemical CRISPR biosensor offers a simple, robust, and highly sensitive platform for DNA detection.
- This technology holds significant potential for nucleic acid-based molecular diagnostics.
- The method simplifies detection processes, making it suitable for rapid screening and diagnosis.
